ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

CTEP-Approved Trials For the Month of June

June 28, 2013

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982

Frei, Freireich Share One GM Prize; Ames, Erikson Win Others

June 17, 1983

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

ASSIST, Largest Antitobacco Effort Ever Undertaken, Concept Approved

October 14, 1988

Grand Jury Clears Eppley, Shubik

October 24, 1980